$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224032357 Filed on August 14, 2024

Income Statement

Concept	2024 Q2
Revenue	$36.62K
YoY Change	-82.21%
Cost Of Revenue	$34.73K
YoY Change	-30.17%
Gross Profit	$1.886K
YoY Change	-98.79%
Gross Profit Margin	5.15%
Selling, General & Admin	$1.263M
YoY Change	-23.76%
% of Gross Profit	66968.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$435.0K
YoY Change	0.0%
% of Gross Profit	23064.69%
Operating Expenses	$2.065M
YoY Change	-16.01%
Operating Profit	-$2.064M
YoY Change	-10.39%
Interest Expense	-$728.7K
YoY Change	-507.82%
% of Operating Profit
Other Income/Expense, Net	-$739.0K
YoY Change	-16684.52%
Pretax Income	-$2.803M
YoY Change	21.93%
Income Tax
% Of Pretax Income
Net Earnings	-$2.803M
YoY Change	21.93%
Net Earnings / Revenue	-7653.47%
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00
COMMON SHARES
Basic Shares Outstanding	1.167B shares
Diluted Shares Outstanding	1.167B shares

Balance Sheet

Concept	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.980K
YoY Change	-92.86%
Cash & Equivalents	$4.978K
Short-Term Investments
Other Short-Term Assets	$161.5K
YoY Change	-90.19%
Inventory	$60.35K
Prepaid Expenses	$161.5K
Receivables	$22.17K
Other Receivables	$0.00
Total Short-Term Assets	$249.0K
YoY Change	-86.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.85M
YoY Change	-12.22%
Goodwill
YoY Change
Intangibles	$5.781M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.66M
YoY Change	-10.54%
Total Long-Term Assets	$26.51M
YoY Change	-11.36%
TOTAL ASSETS
Total Short-Term Assets	$249.0K
Total Long-Term Assets	$26.51M
Total Assets	$26.76M
YoY Change	-15.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.685M
YoY Change	3.93%
Accrued Expenses	$3.502M
YoY Change	57.16%
Deferred Revenue
YoY Change
Short-Term Debt	$900.2K
YoY Change	18.42%
Long-Term Debt Due	$30.94M
YoY Change	815.21%
Total Short-Term Liabilities	$39.67M
YoY Change	274.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities	$38.55K
YoY Change	-63.7%
Total Long-Term Liabilities	$38.55K
YoY Change	-99.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.67M
Total Long-Term Liabilities	$38.55K
Total Liabilities	$39.71M
YoY Change	21.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$186.7M
YoY Change	9.68%
Common Stock	$119.4K
YoY Change	37.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$59.22M
YoY Change
Total Liabilities & Shareholders Equity	$26.76M
YoY Change	-15.61%

Cashflow Statement

Concept	2024 Q2
OPERATING ACTIVITIES
Net Income	-$2.803M
YoY Change	21.93%
Depreciation, Depletion And Amortization	$435.0K
YoY Change	0.0%
Cash From Operating Activities	-$806.4K
YoY Change	-42.44%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$10.00K
YoY Change	-47.37%
Cash From Investing Activities	$10.00K
YoY Change	-149.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$685.8K
YoY Change	-46.19%
NET CHANGE
Cash From Operating Activities	-$806.4K
Cash From Investing Activities	$10.00K
Cash From Financing Activities	$685.8K
Net Change In Cash	-$110.5K
YoY Change	-24.64%
FREE CASH FLOW
Cash From Operating Activities	-$806.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	SHMP	Extension Fee ExtensionFee		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q2	dei	Document Type DocumentType	10-Q
CY2024Q2	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001465470
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares		usd
CY2023Q2	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2024Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2024Q2	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts		usd
CY2024Q2	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
CY2024Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q2	SHMP	Proceeds From Sale Of Preferred Stock Series G ProceedsFromSaleOfPreferredStockSeriesG		usd
CY2024Q2	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	SHMP	Shares Issued Upon Exchange Of Partitioned Note SharesIssuedUponExchangeOfPartitionedNote		usd
CY2024Q2	SHMP	Dividends On Series E Preferred Stock DividendsOnSeriesEPreferredStock		usd
CY2024Q2	SHMP	Shares Issuedto Be Issued For Legal Settlement SharesIssuedtoBeIssuedForLegalSettlement		usd
CY2024Q2	SHMP	Reclass Of Accrued Interest ReclassOfAccruedInterest		usd
CY2024Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q2	dei	Entity File Number EntityFileNumber	000-54030
CY2024Q2	dei	Entity Registrant Name EntityRegistrantName	NATURALSHRIMP INCORPORATED
CY2024Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-3262176
CY2024Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	13601 Preston Road
CY2024Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite E1092
CY2024Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2024Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
CY2024Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
CY2024Q2	dei	City Area Code CityAreaCode	(888)
CY2024Q2	dei	Local Phone Number LocalPhoneNumber	791-9474
CY2024Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q2	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q2	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1236270085	shares
CY2024Q2	us-gaap	Cash Cash	4978	usd
CY2024Q1	us-gaap	Cash Cash	115525	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22165	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27450	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	60352	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	68510	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	161473	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	169650	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	248968	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	381135	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12845980	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301245	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5781000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5878500	usd
CY2024Q2	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	7792376	usd
CY2024Q1	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	8062376	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69717	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73449	usd
CY2024Q2	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2024Q1	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13663726	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14034958	usd
CY2024Q2	us-gaap	Assets Assets	26758674	usd
CY2024Q1	us-gaap	Assets Assets	27717338	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3684727	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3495689	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1842878	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1743799	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19817	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19817	usd
CY2024Q2	us-gaap	Senior Notes Current SeniorNotesCurrent	27690000	usd
CY2024Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	27120000	usd
CY2024Q2	SHMP	Restructured August Note Payable RestructuredAugustNotePayable	2790000	usd
CY2024Q1	SHMP	Restructured August Note Payable RestructuredAugustNotePayable	2640000	usd
CY2024Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	619896	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	544800	usd
CY2024Q2	SHMP	Warrant Liability WarrantLiability	19000	usd
CY2024Q1	SHMP	Warrant Liability WarrantLiability	24000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28560	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28560	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	39666449	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	38528534	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38552	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43325	usd
CY2024Q2	us-gaap	Liabilities Liabilities	39705001	usd
CY2024Q1	us-gaap	Liabilities Liabilities	38571859	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1192874082	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1192874082	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1116482063	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1116482063	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	119351	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	111712	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	127046949	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126468749	usd
CY2024Q2	SHMP	Stock To Be Issued StockToBeIssued	-390024	usd
CY2024Q1	SHMP	Stock To Be Issued StockToBeIssued	-390024	usd
CY2024Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2024Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186717101	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183791156	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-59216527	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-56876421	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26758674	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27717338	usd
CY2024Q2	us-gaap	Revenues Revenues	36618	usd
CY2023Q2	us-gaap	Revenues Revenues	205872	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34732	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49741	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	1886	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	156131	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1104485	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1298451	usd
CY2024Q2	SHMP	Facility Operations FacilityOperations	158535	usd
CY2023Q2	SHMP	Facility Operations FacilityOperations	358258	usd
CY2024Q2	us-gaap	Depreciation Depreciation	434908	usd
CY2023Q2	us-gaap	Depreciation Depreciation	434809	usd
CY2024Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	367500	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	367500	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2065428	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2459018	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2063542	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2302887	usd
CY2024Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5000	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	50000	usd
CY2024Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-720000	usd
CY2023Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	137634	usd
CY2023Q2	SHMP	Extension Fee ExtensionFee	-180000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10357	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5785	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-739006	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4456	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2802548	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2298431	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2802548	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2298431	usd
CY2024Q2	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	48300	usd
CY2024Q2	us-gaap	Dividends Dividends	75097	usd
CY2023Q2	us-gaap	Dividends Dividends	404825	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2925945	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2703256	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1167281937	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1167281937	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	839745626	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	839745626	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-56876421	usd
CY2024Q2	SHMP	Stock Issued During Period Value Issuance Of Common Shares Under Financing Agreement StockIssuedDuringPeriodValueIssuanceOfCommonSharesUnderFinancingAgreement	485839	usd
CY2024Q2	SHMP	Shares Issued Upon Exchange Of Partitioned Note SharesIssuedUponExchangeOfPartitionedNote	100000	usd
CY2024Q2	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	9300	usd
CY2024Q2	SHMP	Preferred Stock Accretion Of Series G Preferred Shares PreferredStockAccretionOfSeriesGPreferredShares	39000	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	75097	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2802548	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-59216527	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-45689165	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-45689165	usd
CY2023Q2	SHMP	Stock Issued During Period Value Issuance Of Common Shares Under Financing Agreement StockIssuedDuringPeriodValueIssuanceOfCommonSharesUnderFinancingAgreement	1298512	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	477175	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	54000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4700	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2298431	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-46261209	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-46261209	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2802548	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2298431	usd
CY2024Q2	SHMP	Depreciation Expense DepreciationExpense	434908	usd
CY2023Q2	SHMP	Depreciation Expense DepreciationExpense	434809	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	367500	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	367500	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-50000	usd
CY2024Q2	SHMP	Change In Fair Value Of Restructured Notes Payable ChangeInFairValueOfRestructuredNotesPayable	720000	usd
CY2023Q2	SHMP	Change In Fair Value Of Restructured Notes Payable ChangeInFairValueOfRestructuredNotesPayable	-137634	usd
CY2024Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	7300	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	120000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10357	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5785	usd
CY2023Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4700	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3732	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	20293	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5285	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19004	usd
CY2024Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8158	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20932	usd
CY2024Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-8177	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-32462	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	55503	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	189038	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35636	usd
CY2024Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	99079	usd
CY2023Q2	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	12032	usd
CY2024Q2	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties	142652	usd
CY2023Q2	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties	171690	usd
CY2024Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	9750	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	6250	usd
CY2024Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4773	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-18981	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-806385	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1400898	usd
CY2023Q2	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	39308	usd
CY2024Q2	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	10000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	19000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20308	usd
CY2023Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	485838	usd
CY2023Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1298512	usd
CY2024Q2	SHMP	Proceeds From Sale Of Preferred Stock Series G ProceedsFromSaleOfPreferredStockSeriesG	200000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	685838	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1274512	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-110547	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-146694	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115525	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	216465	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4978	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69771	usd
CY2024Q2	us-gaap	Interest Paid Net InterestPaidNet	3899	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	7472	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	828000	usd
CY2024Q2	SHMP	Shares Issued Upon Exchange Of Partitioned Note SharesIssuedUponExchangeOfPartitionedNote	100000	usd
CY2023Q2	SHMP	Dividends On Series E Preferred Stock DividendsOnSeriesEPreferredStock	404825	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	75097	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	516000	usd
CY2023Q2	SHMP	Shares Issuedto Be Issued For Legal Settlement SharesIssuedtoBeIssuedForLegalSettlement	272743	usd
CY2024Q2	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_804_eus-gaap--NatureOfOperations_zw8G2MarA72h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_821_zWt8jJ8M9Yu2">NATURE OF THE ORGANIZATION AND BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of the Business</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally-grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. The Company’s production facilities are located in La Coste, Texas and Webster City, Iowa.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation (“NSC”) and NaturalShrimp Global, Inc. (“NS Global”) and Natural Aquatic Systems, Inc. (“NAS”), and owns 51% of NaturalShrimp/Hydrenesis LLC, a Texas limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the three months ended June 30, 2024, the Company had a net loss available for common stockholders of approximately $<span id="xdx_90B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pn3d_di_c20240401__20240630_zWtlPkgctZy5" title="Net loss from operation">2,926,000</span>. As of June 30, 2024, the Company had an accumulated deficit of approximately $<span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20240630_zfvxOFX0b1Xd" title="Accumulated deficit">186,717,000</span> and a working capital deficit of approximately $<span id="xdx_907_ecustom--WorkingCapitalDeficit_iNI_di_c20240630_zvUzoSpTiunh" title="Working capital deficit">39,417,000</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the three months ended June 30, 2024, the Company received net cash proceeds of approximately $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0CC94uwDc0h" title="Sale of stock consideration">486,000</span> from the sale of common shares (See Note 8), and $<span id="xdx_907_ecustom--ProceedFromSaleOfPreferredStock_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zTCCijDviByf" title="Proceeds from sale of Series G Preferred Shares">200,000</span> from the sale of Series G Preferred stock. Subsequent to period end, the Company received approximately $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240701__20240701__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRrUwUuY1uPh" title="Sale of stock consideration">42,000</span> for the sale of common shares and $<span id="xdx_909_ecustom--ProceedFromSaleOfPreferredStock_c20240710__20240710__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zU2hfkBMgbz5" title="Proceeds from sale of Series G Preferred Shares">100,000</span> from the sale of Series G Preferred stock (See Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management believes that private placements of equity capital will be needed to fund the Company’s long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to its common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict its operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter into production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2926000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186717000	usd
CY2024Q2	SHMP	Working Capital Deficit WorkingCapitalDeficit	-39417000	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z0Kh83BnwuUi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_z9SockGL6JIf">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18573116	shares
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	24000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	355000	usd
CY2024Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-331000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	19000	usd
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	24000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	29760000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	23690000	usd
CY2024	SHMP	Reclass Of Accrued Interest ReclassOfAccruedInterest	907634	usd
CY2024Q2	SHMP	Change In Fair Value ChangeInFairValue	720000	usd
CY2024	SHMP	Change In Fair Value ChangeInFairValue	5162366	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	30480000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	29760000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The fair value for both periods is based on the maturity dates, the interest of 12%, the 15% exit fee, the 2% appreciation fee for an estimated period, and a 45% and 40% present value factor
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2022Q4	SHMP	Debt Instrument Exit Fee Percentage DebtInstrumentExitFeePercentage	0.15	pure
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zLjoQoiHWpH3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zUh4ck0NlRvd">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zejv1fHxkMKc" title="Cash, FDIC insured amount">250,000</span>. As of June 30, 2024 and March 31, 2024, the Company’s cash balance did not exceed FDIC coverage. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36618	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	205872	usd
CY2024Q2	us-gaap	Land Land	324293	usd
CY2024Q1	us-gaap	Land Land	324293	usd
CY2024Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6624549	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6624549	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11210985	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11210985	usd
CY2024Q2	SHMP	Automobiles Gross AutomobilesGross	188414	usd
CY2024Q1	SHMP	Automobiles Gross AutomobilesGross	208771	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18348241	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18368598	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5502261	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5067353	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12845980	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13301245	usd
CY2024Q2	us-gaap	Depreciation Depreciation	435000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	435000	usd
CY2024Q2	SHMP	Description For Uplisted Term And Trigger Events DescriptionForUplistedTermAndTriggerEvents	In conjunction with the Merger Agreement, entered into on October 24, 2022, with Yotta Acquisition Corporation, on November 4, 2022, the Company entered into a Restructuring Agreement for an Amended and Restated Secured Promissory Note (the “August Note”), through which the August Note was amended and restated in its entirety. The Restructured August Note decreased the principal to $1,748,667, less an OID of $138,667, and the amount in escrow was returned to the investor, The Restructuring Agreement included key modifications, in which i) the Uplist terms were removed, ii) in the event that the closing of the Merger does not occur on or before December 31, 2022, the then-current Outstanding Balance will be increased by 2% and shall increase by 2% every 30 days thereafter until the closing or termination of the Merger Agreement, and iii) the outstanding balance of the Convertible Note may be increased by 5% to 15% upon the occurrence of an event of default or failure to obtain the Lender’s consent or notify the Lender for certain major equity related transactions (“Trigger Events”).
CY2023Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-06-30
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-08-15
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2016Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2024Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2024Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2021Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2023Q4	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	The monthly rates are $2,063 for April 1, 2024 through March 31, 2025, $2,192 for the second year of April 1, 2025 through March 31, 2026 and $2,320 for the final year
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	2063	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	61000	usd
CY2024Q1	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.145	pure
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	21372	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	30043	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	31590	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	83005	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15893	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	67112	usd

Files In Submission

Name	View Source	Status
0001493152-24-032357-index-headers.html	Edgar Link	pending
0001493152-24-032357-index.html	Edgar Link	pending
0001493152-24-032357.txt	Edgar Link	pending
0001493152-24-032357-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20240630.xsd	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
shmp-20240630_cal.xml	Edgar Link	unprocessable
shmp-20240630_def.xml	Edgar Link	unprocessable
shmp-20240630_lab.xml	Edgar Link	unprocessable
shmp-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2024 Q2 Form 10-Q Financial Statement

#000149315224032357 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2024 Q2 Form 10-Q Financial Statement

#000149315224032357 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp